2020 was a rollercoaster year for the biopharma industry. It was also the year the entire industry changed; from a global response to a worldwide pandemic and an unprecedented effort around vaccine development, consideration of a new drug devel

The Unprecedented Nature of COVID-19 Vaccine Development & Distribution

Nov 16th, 2020 30m 31s

The COVID-19 pandemic remains the number one health concern around the globe as we await approval of multiple vaccines. There are still many unanswered questions and challenges that lie ahead for the biopharma industry, health stakeholders, and

How Biopharma & Providers Can Work Together to Address Health Inequities

Oct 14th, 2020 31m 43s

COVID-19 has put a spotlight on health inequities in our country, with minority populations being impactd at a disproportionate rate. In this episode, host Bob Coughlin and his guests, Kate Walsh, President and CEO at Boston Medical Center and

State of the Biopharma Industry

Sep 14th, 2020 39m

Dr. Michelle McMurry-Heath, President & CEO of BIO, and John Maraganore, CEO of Alnylam, join Bob Coughlin, President & CEO of MassBio and a leading voice for the biotechnology industry, to discuss the biopharma industry’s response to COVID-19,

Trailer

Trailer -State of Possible Podcast

Aug 10th, 2020 50s

The State of Possible is more than a catchy business slogan. It’s both a vision and call to action from the Massachusetts Biotechnology Council. And now it’s also a podcast. The State of Possible Podcast with Bob Coughlin is a new, monthly podc

Rate